Fingerprint
Dive into the research topics where Yuri Pekarsky is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state
Ng, A., Lovat, F., Shih, A. J., Ma, Y., Pekarsky, Y., DiCaro, F., Crichton, L., Sharma, E., Yan, X. J., Sun, D., Song, T., Zou, Y. R., Will, B., Croce, C. M. & Chiorazzi, N., 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 43, e2308658120.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia
Ferlita, A. L., Nigita, G., Tsyba, L., Palamarchuk, A., Alaimo, S., Pulvirenti, A., Balatti, V., Rassenti, L., Tsichlis, P. N., Kipps, T., Pekarsky, Y. & Croce, C. M., 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 44, e2307593120.Research output: Contribution to journal › Article › peer-review
Open Access11 Link opens in a new tab Scopus citations -
tRNA-derived fragments (tRFs) in cancer
Pekarsky, Y., Balatti, V. & Croce, C. M., Mar 2023, In: Journal of Cell Communication and Signaling. 17, 1, p. 47-54 8 p.Research output: Contribution to journal › Review article › peer-review
38 Link opens in a new tab Scopus citations -
A large fraction of trisomy 12, 17p2, and 11q2 CLL cases carry unidentified microdeletions of miR-15a/16-1
Pepe, F., Rassenti, L. Z., Pekarsky, Y., Labanowska, J., Nakamura, T., Nigita, G., Kipps, T. J., Balatti, V. & Croce, C. M., Jan 25 2022, In: Proceedings of the National Academy of Sciences of the United States of America. 119, 4, e2118752119.Research output: Contribution to journal › Article › peer-review
Open Access10 Link opens in a new tab Scopus citations -
Correction to: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential (Oncogene, (2006), 25, 20, (2860-2872), 10.1038/sj.onc.1209323)
Semba, S., Trapasso, F., Fabbri, M., McCorkell, K. A., Volinia, S., Druck, T., Iliopoulos, D., Pekarsky, Y., Ishii, H., Garrison, P. N., Barnes, L. D., Croce, C. M. & Huebner, K., Dec 2 2022, In: Oncogene. 41, 49, p. 5317-5318 2 p.Research output: Contribution to journal › Comment/debate
Open Access1 Link opens in a new tab Scopus citations